u 99194a has been researched along with Anochlesia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andatsu, S; Kizu, T; Miyoshi, S; Ohno, Y; Sato, M; Shimizu, S; Sugiuchi, T; Tatara, A | 1 |
Audinot, V; Bervoets, K; Brocco, M; Dekeyne, A; Desposte, I; Gluck, L; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Rivet, JM | 1 |
2 other study(ies) available for u 99194a and Anochlesia
Article | Year |
---|---|
Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats.
Topics: Animals; Catalepsy; Cerebellum; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Exploratory Behavior; Haloperidol; Indans; Male; Microinjections; Nucleus Accumbens; Piperazines; Pyridines; Rats; Receptors, Dopamine D3; Tetrahydronaphthalenes | 2014 |
A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
Topics: 2-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Biphenyl Compounds; Body Temperature; Catalepsy; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Furans; Humans; Indans; Naphthalenes; Oxazines; Piperazines; Prolactin; Pyrrolidines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3 | 1998 |